BofA raised the firm’s price target on CME Group to $180 from $177 and keeps an Underperform rating on the shares. The firm is revising estimates and targets across the exchanges to account for intra-quarter data points, the analyst tells investors in a Q3 preview note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME: